Life Sciences Update - May 2017

Welcome to our Life Science Issue, a monthly update from the Life Sciences team at S&B, containing news about recent and topical developments.

Contact our experts for further advice

Charlotte Tillett, Gustaf Duhs
  1. SPCs and Markush claims

    The High Court has upheld the validity of GD Searle’s SPC on Prezista, which is used to treat HIV. The decision will be welcomed by patentees for its positive approach to SPCs based on Markush claims.

    Read more
  2. Draft Code of Conduct on Privacy for mHealth Apps under Review

    The Article 29 Working Party (“WP29”) (a European advisory body on data protection and privacy) recently published its comments on the Code of Conduct on privacy for mobile health (mHealth) apps.

     

    Read more
  3. European Medicines Agency launches consultation on draft guideline for the notification of serious clinical trial breaches

    On 23 May 2017, the European Medicines Agency launched a public consultation regarding its draft guideline for the notification of serious breaches of Regulation (EU) No 536/2014 of the clinical trial protocol.

    Read more
  4. The Impact of Brexit on UK IP Rights

    Although much uncertainty still remains, the process of shaping the post-Brexit IP landscape is under way. In this article, we explore some of the main issues and likely outcomes for EU right holders.

     

    Read more
  5. Upcoming Events

    Members of our Life Sciences team, Charlotte Tillett and Gustaf Dufs will be attending the 5th Annual IBA World Life Sciences Conference from 16-17 June and the BIO International Convention from 19-22 June in San Diego.

    We look forward to catching up with many of you at these events. Please get in touch if you would like to arrange a meeting.

Search our site